Effect of quetiapine treatment on facial emotion recognition deficits in schizophrenia patients

Schizophrenia Research

Volumn 119, Issue 1-3, 2010, Pages 275-276

  Cabral Calderin, Yuranny ^a   Mendoza Quiñones, Raúl ^a   Garcia, Alexander ^a   Caballero, Antonio ^b   Domínguez, Mayelín ^a   Reyes, Migdyrai Martín ^a  

^a CUBAN NEUROSCIENCE CENTER   (Cuba)

^b General Hospital Psychiatry Gali García   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; QUETIAPINE;

CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFICACY; EFFECT SIZE; EMOTIONALITY; FACIAL EXPRESSION; HUMAN; LETTER; PRIORITY JOURNAL; RECOGNITION; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DIBENZOTHIAZEPINES; EMOTIONS; FACIAL EXPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATTERN RECOGNITION, VISUAL; SCHIZOPHRENIA, PARANOID; TREATMENT OUTCOME;

EID: 77952668652     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.03.038     Document Type: Letter

References (10)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorder 1994, American Psychiatry Association, Washington. 4th ed.
2. Bediou B., Asri F., Brunelin J., Krolak-Salmon P., D'Amato T., Saoud M., Tazi I. Emotion recognition and genetic vulnerability to schizophrenia. Br. J. Psychiatry 2007, 191:126-130.
3. Behere R.V., Venkatasubramanian G., Arasappa R., Reddy N., Gangadhar B.N. Effect of risperidone on emotion recognition deficits in antipsychotic-naïve schizophrenia: a short-term follow-up study. Schizophr. Res. 2009, 113:72-76.
4. Harvey P.D., Patterson T.L., Potter L.S., Zhong K., Brecher M. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am. J. Psychiatry 2006, 163:1918-1925.
5. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
6. Kee K.S., Kern R.S., Marshall B.D., Green M.F. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophr. Res. 1998, 31:159-165.
7. Lawrence A.D., Goerendt I.K., Brooks D.J. Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia 2007, 45:65-74.
8. Mendoza-Quiñones, R., Cabral-Calderin, Y., Martín, M., Domínguez, M., Caballero, A., García, A., Borrego, M., Guerra, S., in press. Impairment of emotional expression recognition in schizophrenia: a Cuban familial association study. Psychiatry Res. doi:10.1016/j.psychres.2009.10.006.
9. Penn D.L., Keefe R.S., Davis S.M., Meyer P.S., Perkins D.O., Losardo D., Lieberman J.A. The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. Schizophr. Res. 2009, 115:17-23.
10. Russell T.A., Reynaud E., Kucharska-Pietura K., Ecker C., Benson P.J., Zelaya F., Giampietro V., Brammer M., David A., Phillips M.L. Neural responses to dynamic expressions of fear in schizophrenia. Neuropsychologia 2007, 45:107-123.